Added value of 18 F‐florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study-Reference-Cited by-同舟云学术

Added value of 18 F‐florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study

Published:2017-10-26 Issue:3 Volume:14 Page:293-305
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Ceccaldi Mathieu¹,Jonveaux Thérèse²,Verger Antoine³,Krolak‐Salmon Pierre⁴,Houzard Claire⁵,Godefroy Olivier⁶,Shields Trevor⁷,Perrotin Audrey⁸,Gismondi Rossella⁹,Bullich Santiago¹⁰,Jovalekic Aleksandar¹¹,Raffa Nicola¹,Pasquier Florence¹,Semah Franck¹,Dubois Bruno¹,Habert Marie‐Odile¹,Wallon David¹,Chastan Mathieu¹,Payoux Pierre¹,Ceccaldi Mathieu¹,Guedj Eric¹,Ceccaldi Mathieu¹,Felician Olivier¹,Didic Mira¹,Gueriot Claude¹,Koric Lejla¹,Kletchkova‐Gantchev Radka¹,Guedj Eric¹,Godefroy Olivier¹,Andriuta Daniela¹,Devendeville Agnès¹,Dupuis Diane¹,Binot Ingrid¹,Barbay Mélanie¹,Meyer Marc‐Etienne¹,Moullard Véronique¹,Magnin Eloi¹,Chamard Ludivine¹,Haffen Sophie¹,Morel Olivier¹,Drouet Clément¹,Boulahdour Hatem¹,Goas Philippe¹,Querellou‐Lefranc Solène¹,Sayette Vincent¹,Cogez Julien¹,Branger Pierre¹,Agostini Denis¹,Manrique Alain¹,Rouaud Olivier¹,Bejot Yannick¹,Jacquin‐Piques Agnès¹,Dygai‐Cochet Inna¹,Berriolo‐Riedinger Alina¹,Moreaud Olivier¹,Sauvee Mathilde¹,Crépin Céline Gallazzani¹,Pasquier Florence¹,Bombois Stéphanie¹,Lebouvier Thibaud¹,Mackowiak‐Cordoliani Marie‐Anne¹,Deramecourt Vincent¹,Rollin‐Sillaire Adeline¹,Cassagnaud‐Thuillet Pascaline¹,Chen Yaohua¹,Semah Franck¹,Petyt Grégory¹,Krolak‐Salmon Pierre¹,Federico Denis¹,Danaila Keren Liora¹,Guilhermet Yves¹,Magnier Christophe¹,Makaroff Zaza¹,Rouch Isabelle¹,Xie Jing¹,Roubaud Caroline¹,Coste Marie‐Hélène¹,David Kenny¹,Sarciron Alain¹,Waissi Aziza Sediq¹,Scheiber Christian¹,Houzard Claire¹,Gabelle‐Deloustal Audrey¹,Bennys Karim¹,Marelli Cecilia¹,Touati Lynda¹,Mariano‐Goulart Denis¹,Verbizier‐Lonjon Delphine¹,Jonveaux Thérèse¹,Benetos Athanase¹,Kearney‐Schwartz Anna¹,Perret‐Guillaume Christine¹,Verger Antoine¹,Vercelletto Martine¹,Boutoleau‐Bretonniere Claire¹,Pouclet‐Courtemanche Hélène¹,Wagemann Nathalie¹,Pallardy Amandine¹,Hugon Jacques¹,Paquet Claire¹,Dumurgier Julien¹,Millet Pascal¹,Queneau Mathieu¹,Dubois Bruno¹,Epelbaum Stéphane¹,Levy Marcel¹,Habert Marie‐Odile¹²,Novella Jean‐Luc¹,Jaidi Yacine¹,Papathanassiou Dimitri¹,Morland David¹³,Belliard Serge¹,Salmon Anne¹,Lejeune Florence¹,Hannequin Didier¹,Wallon David¹,Martinaud Olivier¹,Zarea Aline¹,Chastan Mathieu¹,Pariente Jérémie¹⁴,Thalamas Claire¹,Galitzky‐Gerber Monique¹⁵,Tricoire Ricard Anne‐Marie¹³,Calvas Fabienne¹,Rigal Emilie¹⁶,Payoux Pierre¹,Hitzel Anne¹,Delrieu Julien¹⁷,Ousset Pierre‐Jean¹,Lala Françoise¹,Sastre‐Hengan Nathalie¹,Stephens Andrew¹,Guedj Eric¹⁸,

Affiliation:

1. AP‐HM–Hôpital de la Timone, Neurology and Neuropsychology Department Aix Marseille University, Inserm, INS, Institut de Neurosciences des Systèmes Marseille France

2. Geriatric Department CHRU de Nancy–Hôpital Brabois Vandoeuvre‐les‐Nancy France

3. INSERM U947 Unité d'Imagerie Adaptative Diagnostique et Interventionnelle Nancy France

4. Clinical and Research Memory Center of Lyon Hospices civils de Lyon, Université Claude Bernard Lyon 1 Inserm 1028 Lyon France

5. Nuclear Medicine Department CHU Lyon Lyon France

6. Neurology Department CHU Amiens Picardie–Hôpital Sud Amiens France

7. Nuclear Medicine Department CHU Amiens Picardie–Hôpital Sud Amiens France

8. Piramal Imaging Clinical Research and Development Berlin Germany

9. Piramal Imaging Market Access and HEOR Berlin Germany

10. AP‐HP–Hôpital Pitié Salpétrière Memory and Alzheimer Disease Institute IM2A Paris France

11. Laboratoire d'Imagerie Biomédicale Sorbonne Universités, UPMC Univ Paris 06, Inserm U 1146, CNRS UMR 7371 Paris France

12. Nuclear Medicine Department Univ. Lille, U1171, CHU Lille Lille France

13. Piramal Imaging Medical Affairs Berlin Germany

14. Nuclear Medicine Department Centre Henri Becquerel Rouen France

15. Inserm 1171 Université de Lille, CHU, DistAlz Lille France

16. ToNIC, Toulouse NeuroImaging Center Université de Toulouse, Inserm, UPS Toulouse France

17. Neurology Department CHU de Rouen–Hôpital Charles Nicolle Rouen France

18. AP‐HM–Hôpital de la Timone, Nuclear Medicine Department Aix‐Marseille University, CERIMED, CNRS, INT, Institut de Neurosciences de la Timone Marseille France

Funder

H. Lundbeck A/S

Novartis

Roche

Pfizer

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2017.09.009

Reference45 articles.

1. 2016 Alzheimer's disease facts and figures

2. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

3. Potential Impact of Amyloid Imaging on Diagnosis and Intended Management in Patients With Progressive Cognitive Decline

4. Amyloid imaging in dementias with atypical presentation

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Les phases prodromique et préclinique de la maladie d’Alzheimer;Pratique Neurologique - FMC;2024-03

2. Incremental value of amyloid PET in a tertiary memory clinic setting in China;Alzheimer's & Dementia;2024-02-08

3. Clinical authorization of amyloid PET in France: Towards a more precise diagnosis of Alzheimer's disease;Médecine Nucléaire;2023-08

4. Patient‐related benefits of amyloid PET imaging in dementia: Rationale and design of the German randomized coverage with evidence development study ENABLE;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2023-07

5. Development of software for measuring brain amyloid accumulation using ¹⁸F‐florbetapir PET and calculating global Centiloid scale and regional Z‐score values;Brain and Behavior;2023-06-07